Management Team:

Board of Directors:

Christopher Cashman, Chairman

Christopher Ragland


Chris Ragland is an experienced Senior Executive with 20+ years of success in the global animal health industry. His assignments have included commercial operations, R&D, business development, and general management. Key areas of responsibility have emphasized strategy development, business integration, research program leadership, and merger/acquisition oversight. After concluding his assignment of President of Intervet Inc. in April 2008, Chris founded Axxiom as an executive consultancy focused on the development and commercialization of new animal health technologies, M&A, strategy development, and business integration initiatives. Over the past 4 years, Chris and the Axxiom team have successfully executed a variety of initiatives for several leading animal health and veterinary distribution companies as well as overseen start-ups in both the veterinary pharmaceutical and biotech markets.


Chris is also CEO of Animalytix, the premier provider of business intelligence services for the US animal health market and co-founder of ATS, an animal health-focused professional training organization located in Kansas City, MO. He is a native of Kentucky and holds a BS in Agricultural Economics & Finance from the University of Kentucky. Chris operates from the Axxiom and Animalytix offices in Salisbury, MD, and Kansas City, MO.


--Close Window--

Thomas Tillett, President & CEO 

Clinical Advisory Board:

Corporate Counsel:

  • LinkedIn Classic
  • Facebook Classic
  • Twitter Social Icon

​Follow us at @mbftherapeutics

© 2020 MBF Therapeutics.   Advanced Immunotherapeutics for Life Sciences.  All rights reserved.